PROQR THRAPEUTICS N V's ticker is PRQR and the CUSIP is N71542109. A total of 53 filers reported holding PROQR THRAPEUTICS N V in Q4 2019. The put-call ratio across all filers is 1.25 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $41,000 | -77.2% | 52,123 | -73.8% | 0.00% | – |
| Q1 2022 | $180,000 | -88.2% | 198,657 | +4.0% | 0.00% | – |
| Q4 2021 | $1,530,000 | +86.4% | 190,987 | +94.7% | 0.00% | – |
| Q3 2021 | $821,000 | +66.2% | 98,073 | +33.8% | 0.00% | – |
| Q2 2021 | $494,000 | +929.2% | 73,273 | +626.6% | 0.00% | – |
| Q3 2020 | $48,000 | -25.0% | 10,085 | -3.8% | 0.00% | – |
| Q2 2020 | $64,000 | +4.9% | 10,486 | -4.9% | 0.00% | – |
| Q1 2020 | $61,000 | -47.9% | 11,026 | -6.7% | 0.00% | – |
| Q4 2019 | $117,000 | -83.6% | 11,824 | -90.5% | 0.00% | – |
| Q3 2019 | $713,000 | -28.3% | 123,870 | +13.4% | 0.00% | – |
| Q2 2019 | $994,000 | -36.8% | 109,260 | -3.6% | 0.00% | – |
| Q1 2019 | $1,573,000 | +132.3% | 113,378 | +164.1% | 0.00% | – |
| Q4 2018 | $677,000 | – | 42,923 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Privium Fund Management B.V. | 5,344,446 | $18,010,783 | 6.83% |
| M28 Capital Management LP | 1,910,600 | $7,069,220 | 6.74% |
| Opaleye Management Inc. | 1,460,000 | $5,402,000 | 1.88% |
| Ikarian Capital, LLC | 422,625 | $1,563,713 | 0.38% |
| Monaco Asset Management SAM | 165,000 | $610,500 | 0.18% |
| AWM Investment Company, Inc. | 166,667 | $616,668 | 0.09% |
| FRANKLIN STREET ADVISORS INC /NC | 150,000 | $555 | 0.05% |
| Atom Investors LP | 18,522 | $68,531 | 0.03% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 3,625,467 | $13,414,228 | 0.03% |
| GSA CAPITAL PARTNERS LLP | 21,514 | $80 | 0.01% |